Annual report pursuant to Section 13 and 15(d)

Commitments and Contingent Liabilities (Tables)

v3.21.1
Commitments and Contingent Liabilities (Tables)
12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Royalty Rates

According to the Agreement, future royalties would be paid to the licensors based on the following royalty rates:

 

On net sales of:   %  
    ●    leukemia related products     3.0  
    ●    other products     2.5  
    ●    in certain limited circumstances, rates may be reduced to     2.0  

 

On fixed sublicense income (with no sublicense income on sales by sub licensee):   %  
    ●    leukemia related products     20.0  
    ●    other products     15.0  

 

On fixed sublicense income (with sublicense income on sales by sub licensee):   %  
    ●    leukemia related products     10.0  
    ●    other products     7.5